NASDAQ · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS · LARGE CAP
GE Healthcare Technologies Inc. GEHC
5 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$20.6B
▲ 4.8% vs FY2024
Dividend streak
2 yrs
Raised every year since 2024
EPS · FY25
$4.55
Dividend / sh · FY25
$0.14
Payout · FY25
3%
ROE · FY25
22.1%
Net margin · FY25
10.1%
Dividend coverage
32.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 20.6B
Revenue, FY2025 · full 5-year series below
Revenue
Net income
10 cents of every revenue dollar became profit this year.
Per share
USD 4.55
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 32.5 times — the rest stayed in the company.
Profitability
22.1%
Return on equity, FY2025
ROE
Operating margin13.4%
Net margin10.1%
Return on assets6.0%
Each USD of equity produced 22 cents of profit this year.
Returned to shareholders
USD 227.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 64.0M
Net buybacksUSD 163.0M
Share of profit10.9%
Consecutive raises2 years
USD 64.0M in dividends and USD 163.0M in buybacks — 11% of the year's profit went back to shareholders.
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.0%
Net income
+2.8%
EPS, diluted
+2.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 36.9B
total assets, end of FY2025
Total assetsUSD 36.9B
EquityUSD 10.4B
CashUSD 4.5B
Gross debtUSD 10.0B
Net debtUSD 5.5B
Current ratio1.37×
Net debt stands at 53% of equity.
History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
Revenue $B
20.6
19.7
19.6
18.3
17.6
Operating income $B
2.8
2.6
2.4
2.5
2.8
EBITDA $B
3.0
2.9
2.7
2.8
3.0
Income tax $B
0.6
0.5
0.7
0.6
0.6
Net income $B
2.1
2.0
1.6
1.9
2.2
EPS, diluted $
4.55
4.34
3.03
4.22
4.95
Dividend / sh $
0.14
0.12
0.12
·
·
Payout %
3
3
3
0
0
ROE %
22.1
25.6
19.0
20.5
·
Shares out B
·
·
0.46
0.45
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
13 of 13
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed